Journal article
Human Leukocyte Antigen Class I-Restricted Activation of CD8 T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
D Chessman, L Kostenko, T Lethborg, AW Purcell, NA Williamson, Z Chen, L Kjer-Nielsen, NA Mifsud, BD Tait, R Holdsworth, CA Almeida, D Nolan, WA Macdonald, JK Archbold, AD Kellerher, D Marriott, S Mallal, M Bharadwaj, J Rossjohn, J McCluskey
Immunity | Published : 2008
Abstract
The basis for strong immunogenetic associations between particular human leukocyte antigen (HLA) class I allotypes and inflammatory conditions like Behçet's disease (HLA-B51) and ankylosing spondylitis (HLA-B27) remain mysterious. Recently, however, even stronger HLA associations are reported in drug hypersensitivities to the reverse-transcriptase inhibitor abacavir (HLA-B57), the gout prophylactic allopurinol (HLA-B58), and the antiepileptic carbamazepine (HLA-B*1502), providing a defined disease trigger and suggesting a general mechanism for these associations. We show that systemic reactions to abacavir were driven by drug-specific activation of cytokine-producing, cytotoxic CD8+ T cells...
View full abstract